Trial
NCT01214655
A Study for Patients With Acute Leukemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Acute Leukemia
Intervention
LY2523355
Why stopped
Primary objective has been met in the absence of clinically meaningful remissions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-13